Michinori Ogura
Nagoya, 4668650, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 93 publications
Final results of JCOG0601 randomized trial of R-CHOP versus CHOP combined with dose-dense rituximab for diffuse large B-cell lymphoma.
Journal: Japanese journal of clinical oncology
Published: May 07, 2025
Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203.
Journal: Hematological oncology
Published: December 29, 2023
R-CHOP treatment for patients with advanced follicular lymphoma: Over 15-year follow-up of JCOG0203.
R-CHOP treatment for patients with advanced follicular lymphoma: Over 15-year follow-up of JCOG0203.
Journal: British journal of haematology
Published: September 01, 2023
Long-term follow-up after R-High CHOP/CHASER/LEED with Auto-PBSCT in untreated mantle cell lymphoma-Final analysis of JCOG0406.
Journal: Cancer science
Published: January 13, 2023
A multicenter, phase II study of full-dose THP-COP therapy for elderly patients with newly diagnosed, advanced-stage, aggressive non-Hodgkin lymphoma.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: December 27, 2022
Interpretable AI Explores Effective Components of CAD/CAM Resin Composites.
Journal: Journal of dental research
Published: April 15, 2022
A phase I/II study of 10-min dosing of bendamustine hydrochloride (rapid infusion formulation) in patients with previously untreated indolent B-cell non-Hodgkin lymphoma, mantle cell lymphoma, or relapsed/refractory diffuse large B-cell lymphoma in Japan.
Journal: Cancer chemotherapy and pharmacology
Published: December 20, 2021
Bendamustine plus rituximab in Japanese patients with relapsed or refractory diffuse large B-cell lymphoma.
Journal: Annals of hematology
Published: October 05, 2021
A multicenter, phase II study of R-THP-COP therapy for elderly patients with newly diagnosed, advanced-stage, indolent B-cell lymphoma.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: July 01, 2021
Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III Study.
Journal: Clinical lymphoma, myeloma & leukemia
Published: June 07, 2021
Clinical characteristics of patients with B-cell lymphoma enrolled in clinical trials for aggressive lymphoma in Japan: Japan Clinical Oncology Group - Lymphoma Study Group study - JCOG0108A.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: March 18, 2021
Last Updated: 09/26/2026